Back to Browse Journals » Clinical Ophthalmology » Volume 1 » Issue 4

Development of the anti-VEGF aptamer to a therapeutic agent for clinical ophthalmology

Authors Cleber A Trujillo, Arthur A Nery, Janaí­na M Alves, Antonio H Martins, Henning Ulrich

Published 15 February 2008 Volume 2007:1(4) Pages 393—402

Cleber A Trujillo1, Arthur A Nery1, Janaína M Alves2, Antonio H Martins1, Henning Ulrich1

1Departamento de Bioquímica, Instituto de Química, Universidade de São Paulo, São Paulo, Brazil; 2Departamento de Neurologia Experimental, Universidade Federal de São Paulo, São Paulo, Brazil

Abstract: Age-related macular degeneration (AMD) is the main cause of loss of sight in the world and is characterized by neovascularization of the macula. The factors producing choroidal vascularization involve various growth factors, including the vascular endothelial growth factor (VEGF165). In this context, the systematic evolution of ligands by exponential enrichment (SELEX) became a tool for developing new therapeutic agents for AMD treatment. The SELEX is a combinatorial oligonucleotide library-based in vitro selection approach in which DNA or RNA molecules (aptamers) are identified by their ability to bind their targets with high affinity and specificity. Recently, the use of the SELEX technique was extended to isolate oligonucleotide ligands for a wide range of proteins of clinical importance. For instance, Pegaptanib sodium, a 28-nucleotide polyethylene glycol RNA aptamer that selectively binds to VEGF165 and inhibits angiogenesis, was approved by the Food and Drug Administration for the treatment of wet AMD, thereby providing significant benefits to a great number of patients with minimal adverse effects.

Keyword: anti-VEGF aptamer, pegaptanib, age-related macular degeneration

Download Article [PDF] 

Readers of this article also read:

Synthesis, pharmacokinetics, and biological use of lysine-modified single-walled carbon nanotubes [Erratum]

Mulvey JJ, Feinberg EN, Alidori S, McDevitt MR, Heller DA, Scheinberg DA

International Journal of Nanomedicine 2015, 10:595-596

Published Date: 14 January 2015

MRI-based identification of undifferentiated cells: looking at the two faces of Janus

Tomuleasa C, Florian IS, Berce C, Irimie A, Berindan-Neagoe I, Cucuianu A

International Journal of Nanomedicine 2014, 9:865-866

Published Date: 11 February 2014

Changes in retinal nerve fiber layer thickness following mechanical microkeratome-assisted versus femtosecond laser-assisted LASIK

Hosny M, Zaki RM, Ahmed RA, Khalil N, Mostafa HM

Clinical Ophthalmology 2013, 7:1919-1922

Published Date: 25 September 2013

Using poly(lactic-co-glycolic acid) microspheres to encapsulate plasmid of bone morphogenetic protein 2/polyethylenimine nanoparticles to promote bone formation in vitro and in vivo

Qiao C, Zhang K, Jin H, Miao L, Shi C, Liu X, Yuan A, Liu J, Li D, Zheng C, Zhang G, Li X, Yang B, Sun H

International Journal of Nanomedicine 2013, 8:2985-2995

Published Date: 13 August 2013

Fabrication of small-diameter vascular scaffolds by heparin-bonded P(LLA-CL) composite nanofibers to improve graft patency

Wang S, Mo XM, Jiang BJ, Gao CJ, Wang HS, Zhuang YG, Qiu LJ

International Journal of Nanomedicine 2013, 8:2131-2139

Published Date: 7 June 2013

Composite scaffolds of mesoporous bioactive glass and polyamide for bone repair

Su J, Cao L, Yu B, Song S, Liu X, Wang Z, Li M

International Journal of Nanomedicine 2012, 7:2547-2555

Published Date: 21 May 2012

Corneal topographic changes following trans-conjunctival 20 gauge sutureless vitrectomy (TC20V)

Abdel Alim Mohamed A, Abdrabbo M

Clinical Ophthalmology 2012, 6:565-569

Published Date: 24 April 2012

A pH-sensitive multifunctional gene carrier assembled via layer-by-layer technique for efficient gene delivery

Li P, Liu DH, Miao L, Liu CX, Sun XL, Liu YJ, Zhang N

International Journal of Nanomedicine 2012, 7:925-939

Published Date: 21 February 2012

Case of endogenous endophthalmitis caused by Streptococcus equisimilis

Shinsuke Suemori, Akira Sawada, Shinya Komori, et al

Clinical Ophthalmology 2010, 4:917-918

Published Date: 12 August 2010

Rheumatic heart disease: 15 years of clinical and immunological follow-up

Roney O Sampaio, Kellen C Fae, Lea MF Demarchi, Pablo MA Pomerantzeff, Vera D Aiello, et al

Vascular Health and Risk Management 2007, 3:1007-1017

Published Date: 15 January 2008